Index RUT
P/E 44.91
EPS (ttm) 0.18
Insider Own 59.63%
Shs Outstand 47.43M
Perf Week -4.20%
Market Cap 378.97M
Forward P/E 4.23
EPS next Y 1.89
Insider Trans 0.00%
Shs Float 19.14M
Perf Month -23.17%
Income 8.43M
PEG -
EPS next Q 0.30
Inst Own 37.30%
Short Float 16.76%
Perf Quarter -61.42%
Sales 2.46B
P/S 0.15
EPS this Y -32.44%
Inst Trans -1.96%
Short Ratio 8.70
Perf Half Y -61.88%
Book/sh 12.62
P/B 0.63
EPS next Y 28.10%
ROA 0.39%
Short Interest 3.21M
Perf Year -75.67%
Cash/sh 3.67
P/C 2.18
EPS next 5Y -
ROE 1.45%
52W Range 7.73 - 36.70
Perf YTD -63.13%
Dividend Est. 0.57 (7.16% )
P/FCF 4.93
EPS past 5Y -25.46%
ROI 0.50%
52W High -78.23%
Beta 1.05
Dividend TTM 0.58 (7.26% )
Quick Ratio 1.61
Sales past 5Y 10.19%
Gross Margin 17.27%
52W Low 3.36%
ATR (14) 0.51
Dividend Ex-Date Apr 02, 2024
Current Ratio 1.61
EPS Y/Y TTM -91.81%
Oper. Margin 5.44%
RSI (14) 32.50
Volatility 4.39% 5.85%
Employees 60000
Debt/Eq 1.89
Sales Y/Y TTM 0.50%
Profit Margin 0.34%
Recom 2.43
Target Price 15.30
Option/Short Yes / Yes
LT Debt/Eq 1.83
EPS Q/Q -144.18%
Payout 585.26%
Rel Volume 0.18
Prev Close 7.76
Sales Surprise 3.76%
EPS Surprise -4.57%
Sales Q/Q -5.25%
Earnings May 08 AMC
Avg Volume 368.73K
Price 7.99
SMA20 -7.31%
SMA50 -31.45%
SMA200 -61.99%
Trades
Volume 10,135
Change 2.96%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-19-24 Initiated
Guggenheim
Sell
$8
Mar-06-24 Downgrade
Canaccord Genuity
Buy → Hold
Mar-04-24 Downgrade
Barrington Research
Outperform → Mkt Perform
Nov-10-23 Upgrade
Barrington Research
Mkt Perform → Outperform
$18
Aug-14-23 Upgrade
Morgan Stanley
Underweight → Equal-Weight
$31
Mar-02-23 Downgrade
Barrington Research
Outperform → Mkt Perform
Oct-10-22 Downgrade
BofA Securities
Buy → Neutral
$68 → $48
Apr-22-22 Initiated
Barrington Research
Outperform
$100
Jan-10-22 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$100 → $90
Mar-05-21 Downgrade
Cowen
Outperform → Market Perform
$85 → $90
Oct-15-20 Initiated
Canaccord Genuity
Buy
$71
Aug-10-20 Downgrade
Sidoti
Buy → Neutral
Jul-23-20 Initiated
Morgan Stanley
Equal-Weight
Jan-17-20 Initiated
Cowen
Outperform
$50
Jan-14-20 Initiated
BofA/Merrill
Buy
$48
Jan-08-20 Initiated
Northland Capital
Outperform
$60
Dec-30-19 Initiated
William Blair
Outperform
Sep-20-19 Initiated
Sidoti
Buy
Aug-29-16 Initiated
Sidoti
Neutral
Aug-08-16 Downgrade
Wells Fargo
Outperform → Market Perform
Show Previous Ratings
Apr-23-24 04:17PM
Apr-18-24 09:00AM
Apr-15-24 04:26PM
Apr-09-24 04:15PM
Apr-02-24 04:15PM
11:04AM
Loading…
Mar-24-24 11:04AM
Mar-12-24 04:15PM
Mar-11-24 09:00AM
Mar-06-24 04:15PM
09:50AM
Mar-04-24 09:08AM
Mar-01-24 10:41PM
(Thomson Reuters StreetEvents) -20.52%
05:12PM
Feb-29-24 05:40PM
04:50PM
(Associated Press Finance)
04:05PM
Loading…
04:05PM
Feb-15-24 04:15PM
Feb-13-24 04:05PM
Jan-23-24 08:30AM
Jan-21-24 03:27PM
Dec-19-23 08:30AM
Dec-12-23 06:35AM
Dec-06-23 08:30AM
Nov-30-23 08:30AM
Nov-29-23 08:30AM
Nov-10-23 12:23PM
Nov-09-23 11:01PM
(Thomson Reuters StreetEvents) -29.41%
Nov-08-23 05:03PM
(Associated Press Finance)
04:05PM
Nov-01-23 12:10PM
10:01AM
Loading…
10:01AM
Oct-17-23 09:05AM
Oct-13-23 07:06AM
Oct-02-23 09:05AM
Sep-20-23 03:16PM
Sep-14-23 08:30AM
Sep-06-23 08:30AM
Aug-31-23 08:30AM
Aug-29-23 08:30AM
Aug-15-23 08:30AM
Aug-10-23 08:30AM
Aug-03-23 08:00PM
06:15PM
05:05PM
04:05PM
Jul-24-23 03:05PM
Jul-06-23 08:30AM
Jul-04-23 02:34PM
Jun-29-23 08:30AM
Jun-21-23 08:00PM
Jun-14-23 08:30AM
Jun-13-23 08:30AM
Jun-07-23 08:30AM
Jun-06-23 02:07PM
May-30-23 08:30AM
May-23-23 01:07PM
May-07-23 08:08AM
May-03-23 06:15PM
05:07PM
04:05PM
04:05PM
Apr-27-23 08:30AM
08:24AM
05:00AM
Apr-26-23 08:00PM
08:30AM
Apr-18-23 04:05PM
01:12PM
Apr-16-23 02:24PM
Apr-13-23 08:30AM
Apr-12-23 08:30AM
Apr-05-23 08:30AM
Mar-27-23 08:30AM
Mar-15-23 08:30AM
Mar-11-23 03:27AM
Mar-03-23 05:09AM
Feb-27-23 05:55PM
04:05PM
04:05PM
Feb-20-23 10:00AM
Feb-08-23 09:30AM
Jan-26-23 08:30AM
Jan-24-23 08:30AM
Jan-18-23 04:50PM
Jan-11-23 12:51PM
09:41AM
08:58AM
08:30AM
Dec-28-22 12:34PM
Dec-15-22 08:30AM
Dec-14-22 12:00PM
Dec-01-22 08:30AM
Nov-28-22 05:39AM
Nov-22-22 08:30AM
Nov-11-22 05:58AM
Nov-09-22 06:25PM
04:05PM
04:05PM
11:44AM
Nov-02-22 10:01AM
TTEC Holdings, Inc. is a digital global customer experience technology and services company. It focuses on the design, implementation, and delivery of transformative solutions for many brands. The firm operates through the following segments: TTEC Digital and TTEC Engage. The TTEC Digital segment provides design, build, and operate tech-enabled, insight-driven CX solutions. The TTEC Engage segment provides digitally-enabled customer care, acquisition, and fraud prevention services. The company was founded by Kenneth D. Tuchman in 1982 and is headquartered in Greenwood Village, CO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
McLean Margaret B GC & CRO Apr 14 '24 Option Exercise 0.00 1,634 0 54,757 Apr 16 04:51 PM Bourret Francois CHIEF ACCOUNTING OFFICER Apr 14 '24 Option Exercise 0.00 1,191 0 6,004 Apr 16 04:44 PM Bourret Francois CHIEF ACCOUNTING OFFICER Mar 17 '24 Option Exercise 0.00 2,718 0 5,832 Mar 19 04:35 PM Swanback Michelle R PRESIDENT, CEO, TTEC ENGAGE Mar 16 '24 Option Exercise 0.00 10,986 0 19,672 Mar 19 04:31 PM McLean Margaret B GC & CRO Mar 04 '24 Option Exercise 0.00 612 0 52,306 Mar 06 04:39 PM McLean Margaret B GC & CRO Jul 01 '23 Option Exercise 0.00 3,239 0 51,937 Jul 05 04:55 PM Bourret Francois INTERIM CFO Jul 01 '23 Option Exercise 0.00 1,431 0 3,236 Jul 05 05:03 PM Holtzman Marc Director Jun 01 '23 Buy 32.32 300 9,696 300 Jun 02 04:49 PM Holtzman Marc Director May 31 '23 Buy 31.40 7,960 249,943 33,229 Jun 02 04:49 PM Holtzman Marc Director May 31 '23 Buy 31.21 1,175 36,671 1,425 Jun 02 04:49 PM Singh-Bushell Ekta Director May 24 '23 Option Exercise 0.00 1,990 0 16,785 May 26 04:48 PM Conley Gregory A Director May 24 '23 Option Exercise 0.00 1,990 0 17,025 May 26 04:51 PM Frerichs Robert N Director May 24 '23 Option Exercise 0.00 1,990 0 18,150 May 26 04:41 PM Anenen Steven Director May 24 '23 Option Exercise 0.00 1,990 0 21,829 May 26 04:45 PM BAHL TRACY L Director May 24 '23 Option Exercise 0.00 1,990 0 17,935 May 26 04:34 PM Holtzman Marc Director May 24 '23 Option Exercise 0.00 1,990 0 25,269 May 26 04:37 PM LOFTEN GINA Director May 24 '23 Option Exercise 0.00 1,990 0 4,195 May 26 04:31 PM Swanback Michelle R PRESIDENT, CEO, TTEC ENGAGE May 02 '23 Option Exercise 0.00 12,191 0 12,191 May 04 04:44 PM
Index -
P/E 6.60
EPS (ttm) 3.58
Insider Own 6.77%
Shs Outstand 4.88M
Perf Week 2.78%
Market Cap 115.27M
Forward P/E -
EPS next Y -
Insider Trans 0.00%
Shs Float 4.55M
Perf Month -6.86%
Income -
PEG -
EPS next Q -
Inst Own 70.76%
Short Float 0.22%
Perf Quarter 9.03%
Sales 1.68M
P/S 68.71
EPS this Y -
Inst Trans -
Short Ratio 0.52
Perf Half Y 24.24%
Book/sh 28.37
P/B 0.83
EPS next Y -
ROA -
Short Interest 0.01M
Perf Year 12.31%
Cash/sh -
P/C -
EPS next 5Y -
ROE -
52W Range 18.30 - 25.56
Perf YTD 0.98%
Dividend Est. -
P/FCF -
EPS past 5Y 0.00%
ROI -
52W High -7.53%
Beta 1.18
Dividend TTM -
Quick Ratio -
Sales past 5Y -
Gross Margin -
52W Low 29.13%
ATR (14) 0.37
Dividend Ex-Date Dec 23, 2022
Current Ratio -
EPS Y/Y TTM -
Oper. Margin -
RSI (14) 44.76
Volatility 1.44% 1.26%
Employees -
Debt/Eq -
Sales Y/Y TTM -
Profit Margin -
Recom -
Target Price -
Option/Short No / Yes
LT Debt/Eq -
EPS Q/Q -
Payout -
Rel Volume 0.04
Prev Close 23.43
Sales Surprise -
EPS Surprise -
Sales Q/Q -50.30%
Earnings -
Avg Volume 18.71K
Price 23.63
SMA20 -2.06%
SMA50 -2.33%
SMA200 5.34%
Trades
Volume 101
Change 0.85%
Index RUT
P/E -
EPS (ttm) -0.00
Insider Own 4.28%
Shs Outstand 54.72M
Perf Week 0.84%
Market Cap 1.62B
Forward P/E 15.23
EPS next Y 1.95
Insider Trans -4.84%
Shs Float 52.39M
Perf Month -12.13%
Income 1.32M
PEG -
EPS next Q 0.26
Inst Own 106.64%
Short Float 8.94%
Perf Quarter 3.22%
Sales 607.52M
P/S 2.67
EPS this Y -30.39%
Inst Trans 1.11%
Short Ratio 12.04
Perf Half Y 27.51%
Book/sh 16.84
P/B 1.76
EPS next Y 18.94%
ROA 0.08%
Short Interest 4.68M
Perf Year -19.33%
Cash/sh 4.66
P/C 6.37
EPS next 5Y 1.69%
ROE 0.15%
52W Range 21.99 - 38.09
Perf YTD 2.44%
Dividend Est. -
P/FCF 14.68
EPS past 5Y -59.02%
ROI 0.14%
52W High -22.17%
Beta 1.02
Dividend TTM -
Quick Ratio 1.43
Sales past 5Y 9.22%
Gross Margin 72.24%
52W Low 34.82%
ATR (14) 1.16
Dividend Ex-Date -
Current Ratio 1.70
EPS Y/Y TTM -97.75%
Oper. Margin 2.21%
RSI (14) 41.81
Volatility 3.92% 3.79%
Employees 652
Debt/Eq 0.05
Sales Y/Y TTM -8.95%
Profit Margin 0.22%
Recom 1.50
Target Price 40.50
Option/Short Yes / Yes
LT Debt/Eq 0.04
EPS Q/Q -94.81%
Payout 0.00%
Rel Volume 0.59
Prev Close 29.31
Sales Surprise 5.99%
EPS Surprise 59.50%
Sales Q/Q -1.80%
Earnings Feb 27 AMC
Avg Volume 388.68K
Price 29.65
SMA20 -5.07%
SMA50 -5.44%
SMA200 1.95%
Trades
Volume 35,739
Change 1.15%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-03-23 Resumed
Jefferies
Buy
$44 → $45
Dec-01-21 Resumed
Jefferies
Buy
$40 → $44
Apr-13-21 Upgrade
Jefferies
Hold → Buy
$25 → $40
Jun-16-20 Upgrade
Piper Sandler
Neutral → Overweight
$25 → $31
Jun-15-20 Resumed
Jefferies
Hold
$24
Nov-08-19 Downgrade
Berenberg
Buy → Hold
Nov-07-19 Downgrade
Stifel
Buy → Hold
$55 → $23
Nov-06-19 Downgrade
Jefferies
Buy → Hold
$46 → $23
Nov-12-18 Reiterated
B. Riley FBR
Buy
$68 → $65
Jan-18-18 Reiterated
B. Riley FBR, Inc.
Buy
$54
Dec-28-17 Reiterated
B. Riley FBR, Inc.
Buy
$50 → $54
Dec-04-17 Upgrade
Janney
Neutral → Buy
Nov-08-17 Upgrade
Stifel
Hold → Buy
$47
Oct-19-17 Initiated
FBR & Co.
Buy
$53
Sep-19-17 Downgrade
Stifel
Buy → Hold
$47
Jul-17-17 Downgrade
Piper Jaffray
Overweight → Neutral
Jul-14-17 Initiated
Janney
Neutral
Jun-01-17 Upgrade
Piper Jaffray
Neutral → Overweight
Jul-18-16 Downgrade
Piper Jaffray
Overweight → Neutral
Jul-18-16 Downgrade
Northland Capital
Outperform → Market Perform
Show Previous Ratings
Apr-24-24 04:05PM
Apr-08-24 12:11PM
08:00AM
Mar-27-24 04:37PM
Mar-06-24 04:30PM
08:28PM
Loading…
Mar-04-24 08:28PM
Feb-28-24 04:30PM
09:19AM
07:17AM
(Thomson Reuters StreetEvents)
Feb-27-24 07:30PM
06:50PM
06:02PM
(Associated Press Finance)
05:00PM
04:05PM
Feb-26-24 09:15AM
10:00AM
Loading…
Feb-20-24 10:00AM
Feb-13-24 04:05PM
Feb-05-24 08:30AM
Dec-19-23 07:30AM
Dec-14-23 07:43PM
Nov-18-23 05:03AM
Nov-10-23 12:10PM
Nov-09-23 09:54AM
(Thomson Reuters StreetEvents) +11.14%
Nov-08-23 07:30PM
07:15PM
06:08PM
(Associated Press Finance)
04:05PM
Nov-07-23 04:30PM
Nov-02-23 07:00AM
Nov-01-23 10:01AM
04:15PM
Loading…
Oct-25-23 04:15PM
Oct-16-23 05:34PM
Oct-09-23 04:45PM
Sep-27-23 04:15PM
Sep-26-23 07:37PM
Sep-09-23 08:00PM
Aug-31-23 05:30PM
Aug-21-23 09:00AM
Aug-08-23 08:30PM
07:55PM
06:40PM
04:17PM
Jul-28-23 02:56PM
Jul-25-23 06:36AM
Jul-24-23 04:05PM
Jun-27-23 11:50AM
Jun-21-23 08:00PM
Jun-10-23 07:40AM
May-31-23 04:15PM
May-11-23 08:39AM
May-10-23 11:23AM
May-09-23 08:30PM
07:05PM
06:09PM
04:05PM
May-02-23 04:05PM
Apr-26-23 08:00PM
Apr-25-23 04:15PM
Apr-03-23 04:05PM
Mar-31-23 12:41PM
Mar-30-23 05:22PM
Mar-08-23 04:05PM
Mar-02-23 08:29PM
Mar-01-23 04:55PM
05:50AM
(Thomson Reuters StreetEvents)
Feb-28-23 05:25PM
04:05PM
Feb-21-23 10:00AM
Feb-14-23 04:30PM
09:27AM
Feb-09-23 06:15PM
Jan-18-23 08:11AM
Jan-03-23 07:11AM
Dec-30-22 12:46AM
Dec-01-22 02:37PM
Nov-22-22 05:00PM
Nov-11-22 05:52AM
Nov-08-22 07:25PM
05:30PM
04:05PM
Oct-25-22 04:30PM
Oct-10-22 08:30AM
Sep-07-22 09:03AM
Aug-31-22 04:00PM
08:55AM
Aug-11-22 08:59AM
Aug-08-22 10:00AM
Aug-04-22 05:25PM
04:01PM
Jul-25-22 05:00PM
Jul-11-22 11:45AM
Jun-02-22 04:05PM
May-09-22 04:05PM
May-02-22 04:55PM
03:08PM
(American City Business Journals)
08:30AM
Apr-29-22 08:00PM
Apr-13-22 04:11PM
Apr-07-22 03:18PM
(Investor's Business Daily)
Apr-04-22 05:00PM
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Bhatt Padmanabh P. Sr. VP of IP, CSO Mar 21 '24 Option Exercise 25.30 14,491 366,622 23,061 Mar 25 05:00 PM Bhatt Padmanabh P. Sr. VP of IP, CSO Mar 21 '24 Sale 35.31 14,491 511,677 8,570 Mar 25 05:00 PM Bhatt Padmanabh P. Sr. VP of IP, CSO Mar 20 '24 Option Exercise 25.30 400 10,120 8,970 Mar 22 05:00 PM Bhatt Padmanabh P. Sr. VP of IP, CSO Mar 20 '24 Sale 35.31 400 14,124 8,570 Mar 22 05:00 PM Bhatt Padmanabh P. Sr. VP of IP, CSO Mar 19 '24 Option Exercise 25.30 12,364 312,809 20,934 Mar 21 05:01 PM Bhatt Padmanabh P. Sr. VP of IP, CSO Mar 19 '24 Sale 35.31 12,364 436,573 8,570 Mar 21 05:01 PM Bhatt Padmanabh P. Sr. VP of IP, CSO Mar 13 '24 Option Exercise 17.61 62,366 1,098,523 44,686 Mar 15 06:39 PM Bhatt Padmanabh P. Sr. VP of IP, CSO Mar 13 '24 Sale 33.74 62,366 2,104,289 8,570 Mar 15 06:39 PM Bhatt Padmanabh P. Sr. VP of IP, CSO Mar 12 '24 Option Exercise 12.98 3,884 50,414 12,454 Mar 14 05:00 PM Bhatt Padmanabh P. Sr. VP of IP, CSO Mar 12 '24 Sale 32.99 3,884 128,133 8,570 Mar 14 05:00 PM Khattar Jack A. President, CEO Feb 28 '24 Option Exercise 0.00 35,000 0 932,005 Feb 29 05:00 PM Mottola Frank SVP, Quality, GMP, Ops, IT Feb 28 '24 Option Exercise 0.00 990 0 8,239 Feb 29 05:01 PM Bhatt Padmanabh P. Sr. VP of IP, CSO Feb 26 '24 Option Exercise 9.13 5,000 45,650 13,570 Feb 28 05:01 PM Bhatt Padmanabh P. Sr. VP of IP, CSO Feb 26 '24 Sale 30.21 5,000 151,050 8,570 Feb 28 05:01 PM Martin Tami Tillotson Sr. V.P., Regulatory Affairs Jan 10 '24 Option Exercise 9.24 8,000 73,920 93,664 Jan 12 05:00 PM Martin Tami Tillotson Sr. V.P., Regulatory Affairs Jan 10 '24 Sale 27.91 8,000 223,280 85,664 Jan 12 05:00 PM Rubin Jonathan Sr. VP, Chief Medical Officer Dec 22 '23 Option Exercise 0.00 600 0 3,447 Dec 26 05:01 PM Khattar Jack A. President, CEO Dec 22 '23 Option Exercise 0.00 25,000 0 892,463 Dec 26 05:00 PM NEWHALL CHARLES W III Director Nov 16 '23 Option Exercise 9.24 7,457 68,903 119,589 Nov 20 05:00 PM NEWHALL CHARLES W III Director Nov 16 '23 Sale 28.01 2,500 70,025 117,089 Nov 20 05:00 PM Hudson Frederick M. Director Nov 15 '23 Option Exercise 9.24 7,457 68,903 42,324 Nov 17 05:00 PM Hudson Frederick M. Director Nov 15 '23 Sale 28.50 9,093 259,150 33,231 Nov 17 05:00 PM Mottola Frank SVP, Quality, GMP, Ops, IT Nov 14 '23 Option Exercise 9.24 2,000 18,480 6,791 Nov 16 05:00 PM Mottola Frank SVP, Quality, GMP, Ops, IT Nov 14 '23 Sale 28.13 1,110 31,224 5,681 Nov 16 05:00 PM DEC TIMOTHY C Senior Vice-President & CFO Oct 13 '23 Option Exercise 0.00 4,000 0 7,000 Oct 13 05:00 PM Khattar Jack A. President, CEO Sep 07 '23 Option Exercise 0.00 35,000 0 884,267 Sep 07 05:00 PM Bhatt Padmanabh P. Sr. VP of IP, CSO Sep 07 '23 Option Exercise 0.00 2,500 0 8,347 Sep 07 05:00 PM Martin Tami Tillotson Sr. V.P., Regulatory Affairs Aug 30 '23 Option Exercise 23.99 8,100 194,319 93,349 Sep 01 05:00 PM Martin Tami Tillotson Sr. V.P., Regulatory Affairs Aug 30 '23 Sale 32.00 8,100 259,200 85,249 Sep 01 05:00 PM Martin Tami Tillotson Sr. V.P., Regulatory Affairs Aug 25 '23 Sale 31.59 5,135 162,215 85,249 Aug 29 05:00 PM Khattar Jack A. President, CEO May 11 '23 Option Exercise 0.00 31,250 0 864,272 May 12 05:00 PM DEC TIMOTHY C Senior Vice-President & CFO May 11 '23 Option Exercise 0.00 1,500 0 3,359 May 12 05:00 PM Bhatt Padmanabh P. Sr. VP of IP, CSO May 11 '23 Option Exercise 0.00 750 0 5,497 May 12 05:00 PM
Index -
P/E -
EPS (ttm) -1.14
Insider Own 1.04%
Shs Outstand 181.36M
Perf Week -1.68%
Market Cap 10.88B
Forward P/E 507.70
EPS next Y 0.12
Insider Trans -5.34%
Shs Float 179.65M
Perf Month -10.38%
Income -204.15M
PEG -
EPS next Q -0.48
Inst Own 87.63%
Short Float 5.51%
Perf Quarter -6.75%
Sales 2.50B
P/S 4.35
EPS this Y 19.50%
Inst Trans -1.74%
Short Ratio 4.01
Perf Half Y -3.03%
Book/sh 17.34
P/B 3.46
EPS next Y 112.98%
ROA -3.00%
Short Interest 9.89M
Perf Year -4.37%
Cash/sh 4.28
P/C 13.99
EPS next 5Y -
ROE -6.60%
52W Range 56.05 - 100.77
Perf YTD -18.98%
Dividend Est. -
P/FCF 340.77
EPS past 5Y 4.59%
ROI -3.63%
52W High -40.52%
Beta 1.26
Dividend TTM -
Quick Ratio 2.07
Sales past 5Y 43.88%
Gross Margin 70.14%
52W Low 6.94%
ATR (14) 3.05
Dividend Ex-Date -
Current Ratio 2.32
EPS Y/Y TTM 67.92%
Oper. Margin -12.20%
RSI (14) 39.06
Volatility 4.44% 4.85%
Employees 6600
Debt/Eq 0.82
Sales Y/Y TTM 19.93%
Profit Margin -8.17%
Recom 1.32
Target Price 90.49
Option/Short Yes / Yes
LT Debt/Eq 0.79
EPS Q/Q 61.80%
Payout -
Rel Volume 0.77
Prev Close 58.79
Sales Surprise 1.26%
EPS Surprise 36.16%
Sales Q/Q 16.98%
Earnings May 08 AMC
Avg Volume 2.47M
Price 59.94
SMA20 -11.51%
SMA50 -5.38%
SMA200 -14.73%
Trades
Volume 292,370
Change 1.95%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-02-24 Upgrade
The Benchmark Company
Hold → Buy
$91
Dec-14-23 Initiated
Guggenheim
Buy
$90
Dec-13-23 Initiated
Wolfe Research
Outperform
$95
Oct-10-23 Upgrade
Piper Sandler
Neutral → Overweight
$90
Sep-28-23 Initiated
Bernstein
Outperform
$83
Aug-02-23 Downgrade
The Benchmark Company
Buy → Hold
May-10-23 Upgrade
Craig Hallum
Hold → Buy
$55 → $85
May-05-23 Initiated
UBS
Neutral
$73
Mar-09-23 Upgrade
Citigroup
Neutral → Buy
$70 → $90
Feb-10-23 Downgrade
Credit Suisse
Outperform → Neutral
$50 → $70
Jan-18-23 Downgrade
Raymond James
Outperform → Mkt Perform
Oct-19-22 Downgrade
Craig Hallum
Buy → Hold
$60 → $35
Aug-25-22 Initiated
Credit Suisse
Outperform
$55
Jun-03-22 Initiated
Piper Sandler
Neutral
$50
Nov-03-21 Downgrade
Raymond James
Strong Buy → Outperform
$160 → $130
Jul-29-21 Reiterated
Stifel
Buy
$165 → $145
Jul-29-21 Reiterated
Oppenheimer
Outperform
$161 → $155
Jul-29-21 Reiterated
Canaccord Genuity
Buy
$185 → $160
Jul-29-21 Reiterated
BTIG Research
Buy
$155 → $145
Jun-15-21 Initiated
Raymond James
Strong Buy
$160
Show Previous Ratings
Apr-25-24 08:05PM
(Morningstar Research) -7.04%
Apr-24-24 06:15PM
07:16AM
Apr-22-24 12:44PM
11:10AM
06:15PM
Loading…
Apr-17-24 06:15PM
Apr-15-24 06:52AM
06:00AM
Apr-12-24 07:00AM
06:49AM
06:40AM
Apr-11-24 06:00AM
Apr-10-24 06:15PM
08:16AM
12:00AM
07:37AM
Loading…
Apr-09-24 07:37AM
Apr-08-24 12:05PM
07:00AM
(The Wall Street Journal)
06:00AM
Apr-05-24 10:16AM
Apr-04-24 10:15AM
06:05AM
Apr-03-24 09:57AM
Apr-02-24 04:02PM
(Investor's Business Daily)
Mar-29-24 08:09AM
Mar-28-24 06:00AM
Mar-27-24 08:05AM
Mar-26-24 07:00AM
Mar-25-24 09:55AM
Mar-22-24 11:30AM
08:19AM
Loading…
Mar-18-24 08:19AM
04:30AM
Mar-14-24 04:16PM
(Investor's Business Daily)
Mar-13-24 05:03PM
Mar-11-24 12:59AM
Mar-08-24 09:55AM
Mar-07-24 07:59AM
Mar-04-24 11:52PM
03:49PM
10:38AM
Mar-03-24 10:32AM
Feb-26-24 06:00AM
Feb-23-24 12:01PM
Feb-22-24 11:08AM
10:30AM
(Thomson Reuters StreetEvents)
10:22AM
01:30AM
12:06AM
Feb-21-24 06:20PM
05:41PM
(Associated Press Finance)
05:12PM
04:05PM
Feb-20-24 02:39AM
Feb-15-24 07:47AM
Feb-14-24 10:00AM
Feb-13-24 08:12PM
Feb-10-24 05:06PM
Feb-07-24 09:00AM
Feb-01-24 06:00AM
Jan-28-24 09:25AM
Jan-22-24 08:00AM
Jan-18-24 05:04AM
Jan-13-24 02:05PM
Jan-08-24 02:48PM
Jan-07-24 04:30PM
Jan-02-24 06:00AM
Dec-21-23 09:43AM
Dec-20-23 01:49PM
Dec-17-23 05:43AM
Dec-14-23 04:02AM
Dec-13-23 12:52PM
08:45AM
Dec-07-23 08:05AM
Dec-05-23 09:11AM
Dec-04-23 12:13PM
Dec-01-23 11:32AM
05:26AM
Nov-30-23 04:05PM
Nov-25-23 09:45AM
Nov-23-23 12:02PM
Nov-20-23 03:06PM
09:55AM
07:30AM
Nov-17-23 08:04PM
(Morningstar Research) +8.39%
07:10AM
Nov-14-23 05:20AM
Nov-10-23 07:00AM
Nov-09-23 08:10PM
(Morningstar Research) -5.09%
Nov-06-23 09:35AM
Nov-03-23 08:09PM
(Morningstar Research) +7.30%
Nov-02-23 07:23PM
04:02PM
(Investor's Business Daily)
11:03AM
09:40AM
(Thomson Reuters StreetEvents)
01:14AM
12:30AM
Nov-01-23 06:06PM
04:05PM
06:00AM
Oct-31-23 05:20PM
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Baranick Brian EVP, GM., Precision Oncology Apr 02 '24 Sale 79.43 924 73,393 13,171 Apr 03 07:30 PM Condella Sarah EVP, Human Resources Apr 01 '24 Sale 70.00 2,000 140,000 71,787 Apr 03 07:30 PM Condella Sarah EVP, Human Resources Mar 28 '24 Sale 70.00 2,000 140,000 73,787 Apr 01 04:30 PM Conroy Kevin T President and CEO Mar 01 '24 Sale 59.32 8,271 490,636 1,299,496 Mar 04 08:38 PM LEVANGIE DANIEL J Director Mar 01 '24 Sale 57.50 5,000 287,500 22,975 Mar 04 08:42 PM Cunningham Everett Chief Commercial Officer Mar 01 '24 Sale 59.32 2,412 143,080 46,179 Mar 04 08:38 PM Elliott Jeffrey Thomas Chief Financial Officer Mar 01 '24 Sale 59.32 2,412 143,080 10,933 Mar 04 08:40 PM Baranick Brian Gen. Mgr., Precision Oncology Mar 01 '24 Sale 59.32 2,323 137,800 14,095 Mar 04 08:36 PM ORVILLE JACOB A General Manager, Screening Mar 01 '24 Sale 59.32 2,154 127,775 14,324 Mar 04 08:42 PM Doyle James Edward Director Mar 01 '24 Sale 57.50 2,000 115,000 50,110 Mar 04 08:39 PM Condella Sarah EVP, Human Resources Mar 01 '24 Sale 59.32 1,724 102,268 75,787 Mar 04 08:37 PM Herriott James General Counsel Mar 01 '24 Sale 59.32 862 51,134 9,125 Mar 04 08:41 PM Herriott James General Counsel Feb 29 '24 Option Exercise 0.00 1,890 0 9,987 Mar 04 08:41 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 29 '24 Option Exercise 0.00 5,291 0 13,345 Mar 04 08:40 PM Cunningham Everett Chief Commercial Officer Feb 29 '24 Option Exercise 0.00 5,291 0 48,591 Mar 04 08:38 PM Conroy Kevin T President and CEO Feb 29 '24 Option Exercise 0.00 18,143 0 1,307,767 Mar 04 08:38 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 29 '24 Option Exercise 0.00 4,724 0 16,418 Mar 04 08:36 PM Condella Sarah EVP, Human Resources Feb 29 '24 Option Exercise 0.00 3,779 0 77,511 Mar 04 08:37 PM ORVILLE JACOB A General Manager, Screening Feb 29 '24 Option Exercise 0.00 4,724 0 16,478 Mar 04 08:42 PM Conroy Kevin T President and CEO Feb 27 '24 Sale 56.89 6,263 356,302 1,289,624 Feb 28 07:35 PM Cunningham Everett Chief Commercial Officer Feb 27 '24 Sale 56.89 3,648 207,535 43,300 Feb 28 07:37 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 27 '24 Sale 56.89 2,710 154,172 8,054 Feb 28 07:36 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 27 '24 Sale 56.89 2,027 115,316 11,694 Feb 28 07:34 PM Condella Sarah EVP, Human Resources Feb 27 '24 Sale 56.89 1,880 106,953 73,732 Feb 28 07:35 PM ORVILLE JACOB A General Manager, Screening Feb 27 '24 Sale 56.89 1,879 106,896 11,754 Feb 28 07:38 PM Herriott James General Counsel Feb 27 '24 Sale 56.89 784 44,602 8,097 Feb 28 07:38 PM ORVILLE JACOB A General Manager, Screening Feb 26 '24 Option Exercise 0.00 3,954 0 13,633 Feb 28 07:38 PM Cunningham Everett Chief Commercial Officer Feb 26 '24 Option Exercise 0.00 7,678 0 46,948 Feb 28 07:37 PM Herriott James General Counsel Feb 26 '24 Option Exercise 0.00 1,648 0 8,881 Feb 28 07:38 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 26 '24 Option Exercise 0.00 5,701 0 10,764 Feb 28 07:36 PM Condella Sarah EVP, Human Resources Feb 26 '24 Option Exercise 0.00 3,954 0 75,612 Feb 28 07:35 PM Conroy Kevin T President and CEO Feb 26 '24 Option Exercise 0.00 13,181 0 1,295,887 Feb 28 07:35 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 26 '24 Option Exercise 0.00 3,954 0 13,721 Feb 28 07:34 PM Conroy Kevin T President and CEO Feb 23 '24 Option Exercise 13.96 102,837 1,435,605 1,344,266 Feb 26 05:00 PM Condella Sarah EVP, Human Resources Feb 23 '24 Sale 59.72 1,021 60,974 71,658 Feb 26 05:00 PM Conroy Kevin T President and CEO Feb 22 '24 Sale 59.78 11,565 691,356 1,241,429 Feb 23 07:59 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 22 '24 Sale 59.78 1,351 80,763 5,063 Feb 23 08:01 PM Cunningham Everett Chief Commercial Officer Feb 22 '24 Sale 59.78 1,350 80,703 39,270 Feb 23 08:00 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 22 '24 Sale 59.78 1,093 65,340 9,767 Feb 23 07:57 PM ORVILLE JACOB A General Manager, Screening Feb 22 '24 Sale 59.78 1,013 60,557 9,679 Feb 23 08:03 PM Condella Sarah EVP, Human Resources Feb 22 '24 Sale 59.78 1,013 60,557 72,679 Feb 23 07:57 PM COWARD D SCOTT Director Feb 22 '24 Sale 59.78 663 39,634 44,493 Feb 23 07:59 PM Herriott James General Counsel Feb 22 '24 Sale 59.78 291 17,396 7,233 Feb 23 08:02 PM Conroy Kevin T President and CEO Feb 21 '24 Sale 61.50 4,975 305,962 1,229,756 Feb 22 07:37 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 21 '24 Sale 61.50 1,493 91,820 3,703 Feb 22 07:38 PM Condella Sarah EVP, Human Resources Feb 21 '24 Sale 61.50 1,079 66,358 71,658 Feb 22 07:36 PM ORVILLE JACOB A General Manager, Screening Feb 21 '24 Sale 61.50 1,078 66,297 8,658 Feb 22 07:40 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 21 '24 Sale 61.50 895 55,042 8,826 Feb 22 07:36 PM COWARD D SCOTT Director Feb 21 '24 Sale 61.50 706 43,419 43,122 Feb 22 07:38 PM Herriott James General Counsel Feb 21 '24 Sale 61.50 415 25,522 6,943 Feb 22 07:39 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 20 '24 Option Exercise 0.00 3,112 0 5,196 Feb 22 07:38 PM Conroy Kevin T President and CEO Feb 20 '24 Option Exercise 0.00 10,374 0 1,234,731 Feb 22 07:37 PM COWARD D SCOTT Director Feb 20 '24 Option Exercise 0.00 2,248 0 43,828 Feb 22 07:38 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 20 '24 Option Exercise 0.00 1,729 0 9,721 Feb 22 07:36 PM Condella Sarah EVP, Human Resources Feb 20 '24 Option Exercise 0.00 2,248 0 72,737 Feb 22 07:36 PM Herriott James General Counsel Feb 20 '24 Option Exercise 0.00 864 0 7,358 Feb 22 07:39 PM ORVILLE JACOB A General Manager, Screening Feb 20 '24 Option Exercise 0.00 2,248 0 9,736 Feb 22 07:40 PM Conroy Kevin T President and CEO Feb 15 '24 Sale 61.43 14,791 908,611 1,224,357 Feb 16 06:22 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 15 '24 Sale 61.43 1,888 115,980 2,084 Feb 16 06:24 PM COWARD D SCOTT Director Feb 15 '24 Sale 61.43 1,376 84,528 41,580 Feb 16 06:23 PM ORVILLE JACOB A General Manager, Screening Feb 15 '24 Sale 61.43 966 59,341 7,488 Feb 16 06:26 PM Condella Sarah EVP, Human Resources Feb 15 '24 Sale 61.43 965 59,280 70,489 Feb 16 06:21 PM Herriott James General Counsel Feb 15 '24 Sale 61.43 421 25,862 6,494 Feb 16 06:25 PM Conroy Kevin T President and CEO Feb 14 '24 Option Exercise 0.00 31,133 0 1,239,148 Feb 16 06:22 PM Condella Sarah EVP, Human Resources Feb 14 '24 Option Exercise 0.00 2,031 0 71,454 Feb 16 06:21 PM Herriott James General Counsel Feb 14 '24 Option Exercise 0.00 883 0 6,915 Feb 16 06:25 PM ORVILLE JACOB A General Manager, Screening Feb 14 '24 Option Exercise 0.00 2,031 0 8,454 Feb 16 06:26 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 14 '24 Option Exercise 0.00 3,972 0 3,972 Feb 16 06:24 PM COWARD D SCOTT Director Feb 14 '24 Option Exercise 0.00 3,972 0 42,956 Feb 16 06:23 PM Condella Sarah EVP, Human Resources Jan 02 '24 Sale 73.50 2,000 147,000 69,423 Jan 04 05:19 PM Baranick Brian Gen. Mgr., Precision Oncology Jan 02 '24 Sale 73.50 879 64,606 7,992 Jan 04 05:17 PM Condella Sarah EVP, Human Resources Dec 14 '23 Sale 70.00 2,000 140,000 71,423 Dec 18 07:49 PM Cunningham Everett Chief Commercial Officer Oct 12 '23 Sale 66.49 13,007 864,835 37,909 Oct 13 07:59 PM Cunningham Everett Chief Commercial Officer Oct 11 '23 Option Exercise 0.00 27,504 0 50,916 Oct 13 07:59 PM Condella Sarah EVP, Human Resources Sep 01 '23 Sale 84.36 4,500 379,620 75,814 Sep 06 04:04 PM Elliott Jeffrey Thomas Chief Financial Officer Aug 21 '23 Sale 82.92 30,210 2,505,013 0 Aug 23 04:08 PM Baranick Brian Gen. Mgr., Precision Oncology Aug 07 '23 Sale 85.04 1,350 114,804 8,871 Aug 08 04:09 PM Baranick Brian Gen. Mgr., Precision Oncology Aug 04 '23 Option Exercise 0.00 2,712 0 10,221 Aug 08 04:09 PM Doyle James Edward Director Jul 27 '23 Sale 97.42 2,000 194,840 52,110 Jul 28 04:06 PM Herriott James General Counsel Jul 19 '23 Sale 100.00 1,300 130,000 5,964 Jul 21 04:04 PM Zanotti Katherine S Director Jun 09 '23 Sale 90.51 3,027 273,974 64,629 Jun 12 04:17 PM Doyle James Edward Director Jun 09 '23 Sale 90.51 1,402 126,895 54,110 Jun 12 04:29 PM Herriott James General Counsel Jun 08 '23 Sale 90.00 1,300 117,000 7,264 Jun 12 04:14 PM Doyle James Edward Director May 26 '23 Sale 80.62 2,000 161,240 51,913 May 31 04:13 PM Condella Sarah EVP, Human Resources May 10 '23 Sale 80.00 6,087 486,960 80,314 May 12 04:11 PM ORVILLE JACOB A General Manager, Screening May 10 '23 Sale 80.00 5,000 400,000 6,423 May 12 04:09 PM Herriott James General Counsel May 10 '23 Sale 79.85 1,300 103,805 8,564 May 12 04:07 PM Condella Sarah EVP, Human Resources May 01 '23 Sale 63.78 1,000 63,780 86,401 May 03 04:04 PM
Category Global or ExUS Equities - Broad / Regional
Asset Type Equities (Stocks)
Tags Europe
Return% 1Y 11.16%
Shs Outstand
Perf Week 2.96%
Sponsor Blackrock (iShares)
ETF Type
Tags Eurozone
Return% 3Y 3.11%
Total Holdings 233
Perf Month -2.18%
Fund Family
Bond Type
Tags equity
Return% 5Y 7.19%
AUM 7.60B
Perf Quarter 5.84%
Index MSCI EMU Index
Average Maturity
Tags mid-large-cap
Return% 10Y
NAV%
Perf Half Y 23.33%
Index Weighting
Commodity Type
Tags -
Return% SI
NAV/sh
Perf Year 8.90%
Active/Passive
Quant Type
Tags -
Flows% 1M 0.00%
52W Range 40.15 - 51.46
Perf YTD 5.75%
Dividend TTM 1.21 (2.42%)
ESG Type
Tags -
Flows% 3M 1.91%
52W High -2.51%
Beta 1.07
Dividend Ex-Date Dec 20, 2023
Dividend Type
Sector/Theme
Flows% YTD 1.91%
52W Low 24.97%
ATR (14) 0.60
Expense 0.51%
Structure Type
Region
Flows% 1Y
RSI (14) 55.06
Volatility 1.09% 1.04%
Option/Short Yes / Yes
Growth/Value
Dev/Emerg
Flows% 3Y
Rel Volume 0.90
Prev Close 49.73
Inverse/Leveraged
Market Cap
Currency
Flows% 5Y
Avg Volume 2.28M
Price 50.17
SMA20 0.52%
SMA50 0.84%
SMA200 8.85%
Trades
Volume 319,685
Change 0.88%
Category Global or ExUS Equities - Country Specific
Asset Type Equities (Stocks)
Tags Finland
Return% 1Y -3.67%
Shs Outstand
Perf Week 2.06%
Sponsor Blackrock (iShares)
ETF Type
Tags equity
Return% 3Y -7.10%
Total Holdings 40
Perf Month 0.86%
Fund Family
Bond Type
Tags -
Return% 5Y 1.68%
AUM 17.54M
Perf Quarter 0.36%
Index MSCI Finland IMI 25/50 Index
Average Maturity
Tags -
Return% 10Y
NAV%
Perf Half Y 16.31%
Index Weighting
Commodity Type
Tags -
Return% SI
NAV/sh
Perf Year -7.22%
Active/Passive
Quant Type
Tags -
Flows% 1M -23.19%
52W Range 30.30 - 39.06
Perf YTD -0.28%
Dividend TTM 1.54 (4.32%)
ESG Type
Tags -
Flows% 3M -9.38%
52W High -8.60%
Beta 0.97
Dividend Ex-Date Dec 20, 2023
Dividend Type
Sector/Theme
Flows% YTD -9.38%
52W Low 17.82%
ATR (14) 0.43
Expense 0.56%
Structure Type
Region
Flows% 1Y
RSI (14) 57.03
Volatility 0.81% 0.78%
Option/Short No / Yes
Growth/Value
Dev/Emerg
Flows% 3Y
Rel Volume 0.03
Prev Close 35.07
Inverse/Leveraged
Market Cap
Currency
Flows% 5Y
Avg Volume 7.30K
Price 35.70
SMA20 1.41%
SMA50 2.14%
SMA200 4.25%
Trades
Volume 27
Change 1.79%
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite